# Study of DC-CTL Combined With CIK for Advanced Solid Tumor

> **NCT03047525** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xiaoyi Huang** · enrollment: 200 (estimated)

## Conditions studied

- Colorectal Cancer
- Renal Cell Carcinoma
- Nasopharyngeal Carcinoma
- Lung Cancer

## Interventions

- **BIOLOGICAL:** Cytokine-induced Killer Cells

## Key facts

- **NCT ID:** NCT03047525
- **Lead sponsor:** Xiaoyi Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-20
- **Primary completion:** 2019-01-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047525, "Study of DC-CTL Combined With CIK for Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03047525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*